214 related articles for article (PubMed ID: 11781245)
1. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas.
Urosevic M; Willers J; Mueller B; Kempf W; Burg G; Dummer R
Blood; 2002 Jan; 99(2):609-17. PubMed ID: 11781245
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2.
Urosevic M; Kamarashev J; Burg G; Dummer R
Blood; 2004 Mar; 103(5):1796-8. PubMed ID: 14592815
[TBL] [Abstract][Full Text] [Related]
3. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
4. HLA-G and IL-10 expression in human cancer--different stories with the same message.
Urosevic M; Dummer R
Semin Cancer Biol; 2003 Oct; 13(5):337-42. PubMed ID: 14708713
[TBL] [Abstract][Full Text] [Related]
5. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
6. Cytokine expression in primary cutaneous germinal center cell lymphomas.
Asadullah K; Gellrich S; Haeussler-Quade A; Friedrich M; Döcke WD; Jahn S; Sterry W
Exp Dermatol; 2000 Feb; 9(1):71-6. PubMed ID: 10688378
[TBL] [Abstract][Full Text] [Related]
7. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
[TBL] [Abstract][Full Text] [Related]
8. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
9. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
10. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
11. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production.
Urosevic M; Kurrer MO; Kamarashev J; Mueller B; Weder W; Burg G; Stahel RA; Dummer R; Trojan A
Am J Pathol; 2001 Sep; 159(3):817-24. PubMed ID: 11549573
[TBL] [Abstract][Full Text] [Related]
13. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
Dogusoy G; Karayel FA; Göcener S; Göksel S
Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
[TBL] [Abstract][Full Text] [Related]
15. HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas.
Bijl JJ; Rieger E; van Oostveen JW; Walboomers JM; Kreike M; Willemze R; Meijer CJ
Am J Pathol; 1997 Oct; 151(4):1067-74. PubMed ID: 9327740
[TBL] [Abstract][Full Text] [Related]
16. BCA-1, A B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders.
Mori M; Manuelli C; Pimpinelli N; Bianchi B; Orlando C; Mavilia C; Cappugi P; Maggi E; Giannotti B; Santucci M
Eur J Cancer; 2003 Jul; 39(11):1625-31. PubMed ID: 12855271
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
18. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.
Curiel-Lewandrowski C; Yamasaki H; Si CP; Jin X; Zhang Y; Richmond J; Tuzova M; Wilson K; Sullivan B; Jones D; Ryzhenko N; Little F; Kupper TS; Center DM; Cruikshank WW
J Clin Invest; 2011 Dec; 121(12):4838-49. PubMed ID: 22080865
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
